100 results
Page 2 of 5
8-K
EX-99.1
1zv1e6no
20 Oct 20
Results of Operations and Financial Condition
10:52am
8-K
EX-2.1
jk5ovxz3y6f9qd44zhtd
13 Oct 20
Entry into a Material Definitive Agreement
8:44am
SC TO-T
EX-99
kagk27klt972rzx1nv6
31 Aug 20
Third party tender offer statement
8:46am
8-K
EX-99.1
qsy3627habslf
6 May 20
Ligand Reports First Quarter 2020 Financial Results
4:03pm
8-K
EX-99.1
tk35wpjjnrn
6 Feb 20
Ligand Reports Fourth Quarter and Full Year 2019 Financial Results
4:05pm
8-K
ua7pxwkvr1lh
16 Oct 19
Ligand Appoints Pharmaceutical Executive Sarah Boyce to its Board of Directors
8:57am
DEFA14A
ncaslb ixwz6xnc1y36
4 Jun 19
Additional proxy soliciting materials
5:07pm